VB Chemical Research LLC’s Post

Here is an excellent contribution from the #LiangYin team at the #ShanghaiInstituteofOrganicChemistry for the catalytic asymmetric α-alkylation of simple carboxylic acid derivatives, which facilitates the preparation of α-chiralcarbonylcompounds through #copper(I)catalysis. Source: https://lnkd.in/gc2GzvqR. #KeyFeaturesoftheMethodology: This innovative approach is characterized by its straightforward reaction protocol, broad functional group tolerance, and exceptional stereocontrol, making it a versatile tool in asymmetric synthesis. #ReactionScopeandReagents :The strategy employs a wide range of alkyl electrophiles, including activated allyl bromides, benzyl bromides, propargyl bromides, and unactivated alkyl sulfonates, which serve as highly effective alkylation reagents.   #PronucleophileCompatibility: A diverse array of pronucleophiles, such as silyl ethers, phosphonates, thioethers, esters, and amides, are well tolerated under the reaction conditions. This highlights the robustness and versatility of the methodology. #ReactionEfficiency: The process consistently delivers products in moderate to high yields with excellent enantioselectivity, ensuring its utility for preparing valuable chiral building blocks. #ExceptionalChemoselectivity: Achieving selective alkylation of 2-acylimidazoles with benzyl bromide in the presence of a phosphonate moiety, as well as preferential alkylation of the 2-acylimidazole moiety over an amide moiety. This high level of selectivity underscores the precision and reliability of the approach in complex molecular settings. #MechanisticInsight – Activation of α-Hydrogens: ¹H NMR studies revealed that 2-acylimidazoles reversibly coordinate to the copper (I) catalyst. This interaction is crucial, as it facilitates the activation of α-hydrogens, thereby enabling highly efficient and selective transformations. This mechanistic understanding highlights the critical role of copper (I) in driving the reaction's precision and effectiveness.   #Applications: This methodology was successfully applied in the #asymmetricformalsynthesis of #AZD2716, a novel and potent secreted phospholipase A2 (sPLA2) inhibitor. Its success underscores its potential for the development of therapeutically significant molecules in pharmaceutical research. #vbchemicalresearch #asymmetricsynthesis #coppercatalysis #oncology #ProcessDevelopment #discoverychemistry #medicinalchemistry #DrugSubstances #CDMO #CRO #networking #Pharma #Biotech #DrugDevelopment #CMC #SmallMolecules #Intermediates #API #Manufacturing

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image

To view or add a comment, sign in

Explore topics